HomeCGTX • NASDAQ
add
Cognition Therapeutics Inc
Previous close
$2.36
Day range
$1.87 - $2.38
Year range
$0.22 - $3.83
Market cap
191.45M USD
Avg Volume
9.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.98M | -4.77% |
Net income | -6.73M | 4.36% |
Net profit margin | — | — |
Earnings per share | -0.11 | 38.89% |
EBITDA | -13.96M | 4.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.74M | -62.35% |
Total assets | 19.62M | -42.91% |
Total liabilities | 12.59M | 10.85% |
Total equity | 7.03M | — |
Shares outstanding | 73.47M | — |
Price to book | 21.45 | — |
Return on assets | -162.07% | — |
Return on capital | -342.56% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -6.73M | 4.36% |
Cash from operations | -5.62M | 6.24% |
Cash from investing | — | — |
Cash from financing | 752.00K | 644.93% |
Net change in cash | -4.87M | 20.64% |
Free cash flow | -8.39M | -3.72% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
25
